Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 517

1.

Testing devices for the prevention and treatment of stroke and its complications.

Bath PM, Brainin M, Brown C, Campbell B, Davis SM, Donnan GA, Ford GA, Hacke W, Iglesias C, Lees KR, Pugh SS, Saver JL, Schellinger PD, Truelsen T.

Int J Stroke. 2014 Aug;9(6):683-95. doi: 10.1111/ijs.12302.

PMID:
25043517
[PubMed - in process]
2.

Hemicraniectomy for middle-cerebral-artery stroke. Author reply.

Jüttler E, Unterberg A, Hacke W.

N Engl J Med. 2014 Jun 12;370(24):2347-8. doi: 10.1056/NEJMc1404585. No abstract available.

PMID:
24918379
[PubMed - indexed for MEDLINE]
Free Article
3.

Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).

Halperin JL, Hankey GJ, Wojdyla DM, Piccini JP, Lokhnygina Y, Patel MR, Breithardt G, Singer DE, Becker RC, Hacke W, Paolini JF, Nessel CC, Mahaffey KW, Califf RM, Fox KA; ROCKET AF Steering Committee and Investigators*.

Circulation. 2014 Jul 8;130(2):138-46. doi: 10.1161/CIRCULATIONAHA.113.005008. Epub 2014 Jun 3.

PMID:
24895454
[PubMed - in process]
4.

Management of acute stroke in patients taking novel oral anticoagulants.

Hankey GJ, Norrving B, Hacke W, Steiner T.

Int J Stroke. 2014 Jul;9(5):627-32. doi: 10.1111/ijs.12295. Epub 2014 Jun 2.

PMID:
24891030
[PubMed - in process]
5.

Time to treatment with recombinant tissue plasminogen activator and outcome of stroke in clinical practice: retrospective analysis of hospital quality assurance data with comparison with results from randomised clinical trials.

Gumbinger C, Reuter B, Stock C, Sauer T, Wiethölter H, Bruder I, Rode S, Kern R, Ringleb P, Hennerici MG, Hacke W; AG Schlaganfall.

BMJ. 2014 May 30;348:g3429. doi: 10.1136/bmj.g3429.

PMID:
24879819
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

[Erratum to: Treatment of asymptomatic carotid artery stenosis].

Reiff T, Amiri H, Fraedrich G, Jansen O, Mudra H, Mansmann U, Hacke W, Ringleb PA, Eckstein HH; SPACE-2 Steering Committee.

Nervenarzt. 2014 Jun;85(6):760. doi: 10.1007/s00115-014-4090-y. German. No abstract available.

PMID:
24849120
[PubMed - in process]
7.

Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF trial.

Steinberg BA, Hellkamp AS, Lokhnygina Y, Halperin JL, Breithardt G, Passman R, Hankey GJ, Patel MR, Becker RC, Singer DE, Hacke W, Berkowitz SD, Nessel CC, Mahaffey KW, Fox KA, Califf RM, Piccini JP; ROCKET AF Steering Committee and Investigators.

Heart Rhythm. 2014 Jun;11(6):925-32. doi: 10.1016/j.hrthm.2014.03.006. Epub 2014 May 13.

PMID:
24833235
[PubMed - in process]
8.

[Professor Brandt retires as Editor : Characterized Der Nervenarzt over 25 years].

Hacke W, Maier W, Braun C.

Nervenarzt. 2014 Jun;85(6):667-8. doi: 10.1007/s00115-014-4071-1. German. No abstract available.

PMID:
24832013
[PubMed - in process]
9.

Rivaroxaban for stroke prevention in East Asian patients from the ROCKET AF trial.

Wong KS, Hu DY, Oomman A, Tan RS, Patel MR, Singer DE, Breithardt G, Mahaffey KW, Becker RC, Califf R, Fox KA, Berkowitz SD, Hacke W, Hankey GJ; Executive Steering Committee and the ROCKET AF Study Investigators.

Stroke. 2014 Jun;45(6):1739-47. doi: 10.1161/STROKEAHA.113.002968. Epub 2014 Apr 24.

PMID:
24763930
[PubMed - in process]
10.

Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation.

Hankey GJ, Stevens SR, Piccini JP, Lokhnygina Y, Mahaffey KW, Halperin JL, Patel MR, Breithardt G, Singer DE, Becker RC, Berkowitz SD, Paolini JF, Nessel CC, Hacke W, Fox KA, Califf RM; ROCKET AF Steering Committee and Investigators.

Stroke. 2014 May;45(5):1304-12. doi: 10.1161/STROKEAHA.113.004506. Epub 2014 Apr 17.

PMID:
24743444
[PubMed - indexed for MEDLINE]
11.

Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial.

Piccini JP, Garg J, Patel MR, Lokhnygina Y, Goodman SG, Becker RC, Berkowitz SD, Breithardt G, Hacke W, Halperin JL, Hankey GJ, Nessel CC, Mahaffey KW, Singer DE, Califf RM, Fox KA; ROCKET AF Investigators.

Eur Heart J. 2014 Jul 21;35(28):1873-80. doi: 10.1093/eurheartj/ehu083. Epub 2014 Mar 21.

PMID:
24658769
[PubMed - in process]
12.

Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke.

Jüttler E, Unterberg A, Woitzik J, Bösel J, Amiri H, Sakowitz OW, Gondan M, Schiller P, Limprecht R, Luntz S, Schneider H, Pinzer T, Hobohm C, Meixensberger J, Hacke W; DESTINY II Investigators.

N Engl J Med. 2014 Mar 20;370(12):1091-100. doi: 10.1056/NEJMoa1311367.

PMID:
24645942
[PubMed - indexed for MEDLINE]
13.

Modification of SPACE-2 study design.

Reiff T, Eckstein HH, Amiri H, Hacke W, Ringleb PA; SPACE-2 Study Group.

Int J Stroke. 2014 Apr;9(3):E12-3. doi: 10.1111/ijs.12253. No abstract available.

PMID:
24636584
[PubMed - in process]
14.

[Therapeutic options in malignant cerebral venous and sinus thrombosis].

Schönenberger S, Geisbüsch C, Nagel S, Hacke W, Bösel J.

Nervenarzt. 2014 Feb;85(2):205-10. doi: 10.1007/s00115-013-3959-5. German.

PMID:
24493062
[PubMed - in process]
15.

[Clinical course of cerebral sinus venous thrombosis. Data from a monocentric cohort study over 15 years].

Geisbüsch C, Lichy C, Richter D, Herweh C, Hacke W, Nagel S.

Nervenarzt. 2014 Feb;85(2):211-20. doi: 10.1007/s00115-013-4000-8. German.

PMID:
24469382
[PubMed - in process]
16.

Author reply.

Heidbuchel H; all the authors of the EHRA Practical Guide:, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, Sinnaeve P, John Camm A, Kirchhof P.

Europace. 2014 Jan;16(1):151-2. doi: 10.1093/europace/eut353. No abstract available.

PMID:
24344327
[PubMed - in process]
17.

[Treatment of asymptomatic carotid artery stenosis: improvement of evidence with new SPACE-2 design necessary].

Reiff T, Amiri H, Ringleb PA, Jansen O, Hacke W, Eckstein HH.

Nervenarzt. 2013 Dec;84(12):1504-7. doi: 10.1007/s00115-013-3906-5. German.

PMID:
24337619
[PubMed - in process]
18.

Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation).

Goodman SG, Wojdyla DM, Piccini JP, White HD, Paolini JF, Nessel CC, Berkowitz SD, Mahaffey KW, Patel MR, Sherwood MW, Becker RC, Halperin JL, Hacke W, Singer DE, Hankey GJ, Breithardt G, Fox KA, Califf RM; ROCKET AF Investigators.

J Am Coll Cardiol. 2014 Mar 11;63(9):891-900. doi: 10.1016/j.jacc.2013.11.013. Epub 2013 Dec 4.

PMID:
24315894
[PubMed - indexed for MEDLINE]
19.

Prolonged low-dose thrombolysis in posterior circulation stroke.

Hametner C, Kellert L, Veltkamp R, Behrens L, Nagel S, Hacke W, Ringleb P.

Neurocrit Care. 2014 Aug;21(1):114-8. doi: 10.1007/s12028-013-9891-5.

PMID:
24248735
[PubMed - in process]
20.

Stroke treatment academic industry roundtable: research priorities in the assessment of neurothrombectomy devices.

Saver JL, Jovin TG, Smith WS, Albers GW, Baron JC, Boltze J, Broderick JP, Davis LA, Demchuk AM, DeSena S, Fiehler J, Gorelick PB, Hacke W, Holt B, Jahan R, Jing H, Khatri P, Kidwell CS, Lees KR, Lev MH, Liebeskind DS, Luby M, Lyden P, Megerian JT, Mocco J, Muir KW, Rowley HA, Ruedy RM, Savitz SI, Sipelis VJ, Shimp SK 3rd, Wechsler LR, Wintermark M, Wu O, Yavagal DR, Yoo AJ; STAIR VIII Consortium.

Stroke. 2013 Dec;44(12):3596-601. doi: 10.1161/STROKEAHA.113.002769. Epub 2013 Nov 5.

PMID:
24193797
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk